Changes in ctDNA can predict long-term outcomes in certain patients with metastatic CRC on immune checkpoint inhibitors.

Discover insights on the challenges of CTCs and ctDNA from liquid biopsies as cancer diagnostic tools, how novel technology is helping to overcome some of these issues and the future monitoring ...

FTIR microscopy is a game-changer for analyzing complex samples at the micro level. It combines the precision of FTIR with advanced imaging, allowing us to map chemical compositions or identify ...

Quality assurance is critical in the food industry for consumer trust, learn how to conduct foreign body identification via FTIR and handheld XRF.

Abstract Purpose To determine whether treatment with TAS-102 can induce circulating tumor DNA (ctDNA) clearance at 6 months and delay/prevent disease recurrence in colorectal cancer (CRC) patients ...

Patients and providers find the Colon Age tool acceptable and useful for individualizing colorectal cancer risk and encouraging earlier screening.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Direct ...

No. 6 June 2025 Detecting minimal residual cancer from ctDNA A tumor-agnostic assay for detecting minimal residual cancer based on whole-exome sequencing of longitudinal ctDNA samples after surgery.